Dramatic Improvement of Treatment-Refractory Prurigo Nodularis Following Initiation of Semaglutide: A Case Report. [PDF]
Fougerousse AC.
europepmc +1 more source
Direct randomized evidence for systemic targeted therapies in prurigo nodularis: a systematic review and meta-analysis. [PDF]
Yu Y, Li S, Chen W, Chen X.
europepmc +1 more source
Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab
Joshua D. Bloomstein, BS +1 more
doaj +1 more source
Case Report: Dupilumab-associated psoriasiform eruption followed by depigmentation in a patient with prurigo nodularis and Vogt-Koyanagi-Harada disease. [PDF]
Otsuka M, Sato E, Katayama S, Imafuku S.
europepmc +1 more source
Upadacitinib for prurigo nodularis
Clara Muntaner-Virgili, MD +3 more
openaire +3 more sources
Use of dupilumab in the management of refractory prurigo nodularis in an immunosuppressed double transplanted patient. [PDF]
Valenzuela Godoy D +2 more
europepmc +1 more source
Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis. [PDF]
Ständer S +8 more
europepmc +1 more source
Refractory bullous pemphigoid with prurigo nodularis successfully treated with dupilumab monotherapy
Po-Ta Lai, Han-Chi Tseng
doaj +1 more source
Prurigo Nodularis in Lepromatous Leprosy: A Manifestation of Neuropathic Pruritus and Denervation Dermatopathy. [PDF]
Sharma A, Chatterjee D, Narang T.
europepmc +1 more source
Correction: Ivarmacitinib in atopic dermatitis presenting with prurigo nodularis-like lesions and alopecia areata: a case report. [PDF]
Liao X, Lu Y.
europepmc +1 more source

